These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37036587)

  • 21. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
    Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
    Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy.
    Lim SB; Yu CS; Kim CW; Yoon YS; Park SH; Kim TW; Kim JH; Kim JC
    Int J Colorectal Dis; 2013 Dec; 28(12):1667-74. PubMed ID: 23943283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiologic Factors and Areas of Local Recurrence in Locally Advanced Lower Rectal Cancer After Lateral Pelvic Lymph Node Dissection.
    Shiraishi T; Sasaki T; Tsukada Y; Ikeda K; Nishizawa Y; Ito M
    Dis Colon Rectum; 2021 Dec; 64(12):1479-1487. PubMed ID: 34657076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is neoadjuvant chemoradiotherapy sufficient in patients with advanced rectal malignancy and positive extra-mesorectal lateral lymph nodes?
    Ahmadi N; Brown KGM; Lee P; Quinn M; Austin KKS; Solomon MJ
    Colorectal Dis; 2020 Jun; 22(6):689-693. PubMed ID: 31909851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncologic benefit of adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and curative surgery with selective lateral pelvic lymph node dissection: An international retrospective cohort study.
    Fukui Y; Hida K; Hoshino N; Song SH; Park SY; Choi GS; Maeda Y; Matoba S; Kuroyanagi H; Bae SU; Jeong WK; Baek SK; Sakai Y
    Eur J Surg Oncol; 2022 Jul; 48(7):1631-1637. PubMed ID: 35153105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of neoadjuvant therapy on the size, number, and distribution of mesorectal lymph nodes.
    Yegen G; Keskin M; Büyük M; Kunduz E; Balık E; Sağlam EK; Kapran Y; Asoğlu O; Güllüoğlu M
    Ann Diagn Pathol; 2016 Feb; 20():29-35. PubMed ID: 26706785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery.
    Hajibandeh S; Hajibandeh S; Matthews J; Palmer L; Maw A
    Surgery; 2020 Sep; 168(3):486-496. PubMed ID: 32620303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary experience with lateral pelvic lymph node dissection in locally advanced rectal cancer.
    Sinukumar S; Engineer R; Saklani A
    Indian J Gastroenterol; 2015 Jul; 34(4):320-4. PubMed ID: 26334237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
    Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
    Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between preoperative chemoradiotherapy and lateral pelvic lymph node dissection in clinical T3 low rectal cancer without enlarged lateral lymph nodes.
    Tsukada Y; Rullier E; Shiraishi T; Capdepont M; Sasaki T; Celerier B; Denost Q; Ito M
    Colorectal Dis; 2023 Jun; 25(6):1153-1162. PubMed ID: 36932710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.
    Matsuda T; Sumi Y; Yamashita K; Hasegawa H; Yamamoto M; Matsuda Y; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
    Int J Colorectal Dis; 2018 Apr; 33(4):367-374. PubMed ID: 29442155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lateral lymph node dissection for low rectal cancer: Is it necessary?
    Christou N; Meyer J; Toso C; Ris F; Buchs NC
    World J Gastroenterol; 2019 Aug; 25(31):4294-4299. PubMed ID: 31496614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy.
    Abdel-Misih SR; Wei L; Benson AB; Cohen S; Lai L; Skibber J; Wilkinson N; Weiser M; Schrag D; Bekaii-Saab T
    J Natl Compr Canc Netw; 2016 Dec; 14(12):1528-1534. PubMed ID: 27956537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
    Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
    J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesorectal excision with or without lateral lymph node dissection for elderly patients with mid-low rectal cancer: safety and feasibility analysis.
    Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q;
    Jpn J Clin Oncol; 2023 Jan; 53(1):26-34. PubMed ID: 36354102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
    Gao X; Wang C; Yu Y; Singh D; Yang L; Zhou Z
    World J Surg Oncol; 2020 Nov; 18(1):304. PubMed ID: 33228677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.
    Sapci I; Delaney CP; Liska D; Amarnath S; Kalady MF; Steele SR; Gorgun E
    J Gastrointest Surg; 2019 Jul; 23(7):1454-1460. PubMed ID: 31012043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.
    He F; Chen M; Xiao WW; Zhang Q; Liu Y; Zheng J; Wan XB; Gao YH
    Jpn J Clin Oncol; 2021 Aug; 51(9):1391-1399. PubMed ID: 34155513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer.
    Scabini S; Montecucco F; Nencioni A; Zoppoli G; Sartini M; Rimini E; Massobrio A; De Marini L; Poggi A; Boaretto R; Romairone E; Ballestrero A; Ferrando V
    World J Surg Oncol; 2013 Nov; 11():292. PubMed ID: 24246069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.